Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
17.6M
-
Shares change
-
-474K
-
Total reported value, excl. options
-
$132M
-
Value change
-
-$4.24M
-
Put/Call ratio
-
2.23
-
Number of buys
-
22
-
Number of sells
-
-33
-
Price
-
$7.55
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2023
90 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q3 2023.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.6M shares
of 37.4M outstanding shares and own 47.15% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (4.92M shares), Legion Partners Asset Management, LLC (2.94M shares), 22NW, LP (1.76M shares), VANGUARD GROUP INC (1.35M shares), Cove Street Capital, LLC (1.11M shares), MORGAN STANLEY (795K shares), MILLENNIUM MANAGEMENT LLC (613K shares), BlackRock Inc. (511K shares), Visionary Wealth Advisors (501K shares), and TOCQUEVILLE ASSET MANAGEMENT L.P. (402K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.